What is Bristol-Myers Squibb's expected EPS for Q2 2026?

Analysts expect Bristol-Myers Squibb (BMY) to report consensus EPS of approximately $1.60 for Q2 2026. Estimates range from $1.48 to $1.68.

What revenue do analysts expect for Bristol-Myers Squibb in Q2 2026?

The consensus revenue forecast for Bristol-Myers Squibb (BMY) in Q2 2026 is approximately $11.7B. Forecasts range from $11.5B to $12B.

How many analysts cover Bristol-Myers Squibb?

15 analysts contribute to the Bristol-Myers Squibb (BMY) Q2 2026 consensus estimate.

Has Bristol-Myers Squibb beaten earnings estimates recently?

Bristol-Myers Squibb beat analyst EPS estimates in 2 of the last 2 quarters. Bristol-Myers Squibb beat revenue estimates in 2 of 2. In the most recent quarter (Q1 2026), Bristol-Myers Squibb EPS beat by 11% and revenue beat by 5.1%.

When does Bristol-Myers Squibb report Q2 2026 earnings?

Bristol-Myers Squibb (BMY) is expected to report Q2 2026 earnings on July 30, 2026 before market open.

BMY Q2 2026 earnings estimate

Consensus EPS · Q2 2026

$1.60

Consensus revenue · Q2 2026

$11.7B

Analysts

Expected report

Jul 30, 2026

Before open

Upcoming earnings

Locks in 6 days 13 hours · BMO: Locks 8:00 PM ET previous day

Revenue$11.7B$11.5B – $12B

EPS$1.60$1.48 – $1.68

What to watch

Analyst ratings: Mixed

Make your prediction

Analyst consensus

Based on estimates from 15 analysts.

Metric	Low	Consensus	High
Revenue	$11.5B	$11.7B	$12B
EPS	$1.48	$1.60	$1.68
EBITDA	$3.7B	$3.9B	$4B
EBIT	$1.6B	$1.6B	$1.7B
Net income	$3.1B	$3.3B	$3.3B

Revenue$11.7B
EPS$1.60
EBITDA$3.9B
EBIT$1.6B
Net income$3.3B

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q1 2026	$11.5B	$10.9B	+5.1%	$1.58	$1.42	+11.0%
Q4 2025	$12.5B	$12.3B	+1.8%	$1.26	$1.23	+2.8%

Q1 2026+5.1%+11.0%
Q4 2025+1.8%+2.8%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Bristol-Myers Squibb (BMY) Q2 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 0 analysts.

Low: $40.00
Consensus: $63.25
Median: $65.00
High: $75.00
Current: $60.76
Upside: +4.1%

Upside calculated vs most recent trading price of $60.76.

Analyst ratings

Consensus: Hold — based on 41 analyst ratings.

Buy 19Hold 20Sell 2

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
Jul 10, 2026	B of A Securities	maintain	Buy	Buy
Jul 6, 2026	Cantor Fitzgerald	maintain	Neutral	Neutral
Apr 9, 2026	B of A Securities	maintain	Buy	Buy
Apr 8, 2026	Guggenheim	maintain	Buy	Buy
Apr 8, 2026	Cantor Fitzgerald	maintain	Neutral	Neutral
Mar 17, 2026	HSBC	maintain	Hold	Hold
Feb 23, 2026	Piper Sandler	maintain	Overweight	Overweight
Feb 6, 2026	Wells Fargo	maintain	Equal Weight	Equal Weight
Feb 6, 2026	Guggenheim	maintain	Buy	Buy
Feb 6, 2026	Citigroup	maintain	Neutral	Neutral

Jul 10, 2026B of A SecuritiesBuy
Jul 6, 2026Cantor FitzgeraldNeutral
Apr 9, 2026B of A SecuritiesBuy
Apr 8, 2026GuggenheimBuy
Apr 8, 2026Cantor FitzgeraldNeutral
Mar 17, 2026HSBCHold
Feb 23, 2026Piper SandlerOverweight
Feb 6, 2026Wells FargoEqual Weight
Feb 6, 2026GuggenheimBuy
Feb 6, 2026CitigroupNeutral

Frequently asked questions

Bristol-Myers Squibb (BMY) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

BMY Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation